The portfolio maintains a cost advantage over competitors, priced within the lowest fee quintile among peers.
iShares Biotechnology ETF IBB
Morningstar’s Analysis IBB
Will IBB outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 52.4
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Regeneron Pharmaceuticals Inc | 8.39 | 610.1 Mil | Healthcare |
Gilead Sciences Inc | 8.38 | 609.2 Mil | Healthcare |
Vertex Pharmaceuticals Inc | 8.19 | 595.5 Mil | Healthcare |
Amgen Inc | 8.00 | 581.6 Mil | Healthcare |
Moderna Inc | 4.01 | 291.1 Mil | Healthcare |
IQVIA Holdings Inc | 3.73 | 271.0 Mil | Healthcare |
Biogen Inc | 3.36 | 244.1 Mil | Healthcare |
Alnylam Pharmaceuticals Inc | 3.16 | 230.0 Mil | Healthcare |
Mettler-Toledo International Inc | 2.90 | 210.7 Mil | Healthcare |
argenx SE ADR | 2.24 | 162.5 Mil | Healthcare |